HEALTH● LOWSep 8 · Sep 8, 2026, 11:20 AM
Bristol Myers succeeds in mid-stage trial for CAR-T cell therapy in multiple myeloma
Seeking Alpha Tech · global
Bristol Myers has achieved success in a mid-stage trial for its CAR-T cell therapy, which targets multiple myeloma. This marks progress in the development of treatments for the condition.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH51m agoThree Chili’s customers chemically burned after margarita mix-upThe Independent WorldHEALTH2h agoAmericans face higher costs and fewer options as Affordable Care Act open enrollment beginsThe Independent WorldHEALTH2h agoJohnson & Johnson reports lower mortality rates with Impella heart pumpsSeeking Alpha TechHEALTH3h agoNotable healthcare headlines for the week: Eli Lilly, Merck, and AstraZeneca in focusSeeking Alpha Tech